Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3741
Source ID: NCT01467401
Associated Drug: Biphasic Insulin Aspart
Title: Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic insulin aspart|DRUG: biphasic human insulin
Outcome Measures: Primary: HbA1c (glycolated haemoglobin) | Secondary: Prandial increment in blood glucose|7-point blood glucose profile|Number and severity of adverse events|Number and severity of local tolerability issues at the injection site|Number and severity of hypoglycaemic episodes
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 292
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2002-08-19
Completion Date: 2003-05-15
Results First Posted:
Last Update Posted: 2017-02-24
Locations: Novo Nordisk Investigational Site, Esbjerg, 6700, Denmark|Novo Nordisk Investigational Site, Herning, 7400, Denmark|Novo Nordisk Investigational Site, Holbæk, 4300, Denmark|Novo Nordisk Investigational Site, Næstved, 4700, Denmark|Novo Nordisk Investigational Site, Randers, Denmark|Novo Nordisk Investigational Site, Silkeborg, 8600, Denmark|Novo Nordisk Investigational Site, Skive, 7800, Denmark|Novo Nordisk Investigational Site, Viborg, Denmark|Novo Nordisk Investigational Site, Århus C, 8000, Denmark|Novo Nordisk Investigational Site, Bekkestua, 1357, Norway|Novo Nordisk Investigational Site, Bergen, NO-5012, Norway|Novo Nordisk Investigational Site, Haugesund, Norway|Novo Nordisk Investigational Site, Hønefoss, Norway|Novo Nordisk Investigational Site, Moelv, Norway|Novo Nordisk Investigational Site, Oslo, 0370, Norway|Novo Nordisk Investigational Site, Tromsø, 9038, Norway|Novo Nordisk Investigational Site, Vennesla, Norway|Novo Nordisk Investigational Site, Åsgårdstrand, Norway|Novo Nordisk Investigational Site, Arvika, 671 80, Sweden|Novo Nordisk Investigational Site, Avesta, 774 82, Sweden|Novo Nordisk Investigational Site, Bjuv, 267 38, Sweden|Novo Nordisk Investigational Site, Broby, 280 60, Sweden|Novo Nordisk Investigational Site, Färgelanda, 458 32, Sweden|Novo Nordisk Investigational Site, Grästorp, 467 22, Sweden|Novo Nordisk Investigational Site, Göteborg, 416 65, Sweden|Novo Nordisk Investigational Site, Göteborg, 416 85, Sweden|Novo Nordisk Investigational Site, Göteborg, 417 02, Sweden|Novo Nordisk Investigational Site, Göteborg, 417 17, Sweden|Novo Nordisk Investigational Site, Habo, 566 32, Sweden|Novo Nordisk Investigational Site, Helsingborg, 254 57, Sweden|Novo Nordisk Investigational Site, Härnösand, 871 82, Sweden|Novo Nordisk Investigational Site, Hässleholm, 281 25, Sweden|Novo Nordisk Investigational Site, Jönköping, 551 11, Sweden|Novo Nordisk Investigational Site, Karlstad, 651 85, Sweden|Novo Nordisk Investigational Site, Karlstad, 652 24, Sweden|Novo Nordisk Investigational Site, Kristianstad, 291 38, Sweden|Novo Nordisk Investigational Site, Kristinehamn, 681 80, Sweden|Novo Nordisk Investigational Site, Kungsbacka, 434 80, Sweden|Novo Nordisk Investigational Site, Malmö, 205 02, Sweden|Novo Nordisk Investigational Site, Mellerud, 464 30, Sweden|Novo Nordisk Investigational Site, Mölndal, 431 80, Sweden|Novo Nordisk Investigational Site, Norrköping, 602 36, Sweden|Novo Nordisk Investigational Site, Skövde, 541 85, Sweden|Novo Nordisk Investigational Site, Stockholm, 116 91, Sweden|Novo Nordisk Investigational Site, Säffle, 661 81, Sweden|Novo Nordisk Investigational Site, Tomelilla, 273 34, Sweden|Novo Nordisk Investigational Site, Torsby, 685 29, Sweden|Novo Nordisk Investigational Site, Trollhättan, 461 40, Sweden|Novo Nordisk Investigational Site, Trollhättan, 461 85, Sweden|Novo Nordisk Investigational Site, Tyresö, 135 21, Sweden|Novo Nordisk Investigational Site, Uddevalla, 451 80, Sweden|Novo Nordisk Investigational Site, Värnamo, 331 85, Sweden|Novo Nordisk Investigational Site, Örebro, 701 85, Sweden|Novo Nordisk Investigational Site, Örebro, 702 15, Sweden|Novo Nordisk Investigational Site, Örebro, 703 51, Sweden|Novo Nordisk Investigational Site, Östersund, 831 62, Sweden|Novo Nordisk Investigational Site, Östersund, 831 83, Sweden
URL: https://clinicaltrials.gov/show/NCT01467401

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress